Jack Hoppin, Ph.D.
Chairman, Chief Executive Officer
Konica-Minolta Precision Medicine (President), Invicro (Co-Founder), Emit Imaging (Co-Founder, Chairman)
John Babich, Ph.D.
Director, President, Chief Scientific Officer
Weill Cornell Medicine, Molecular Insight
Pharmaceuticals (Co-Founder), MGH/HMS, RMH/ICR,
Allan Green, M.D., Ph.D., J.D.
Director & Regulatory Consultant
Ground Fluor Pharmaceuticals, Atreus
Pharmaceuticals, Theseus Imaging, NASI, NEN, Boston College Law School
Kelly Orcutt, Ph.D.
Head of Pharmacology
Viewpoint Molecular Targeting, Invicro, University of Iowa, Harvard Medical School, MIT
Matthias Friebe, Ph.D.
Chief Technology Officer
Piramal Imaging, Bayer AG, Schering AG, Harvard Medical School, Swiss Federal Institute of Technology
Shawn Hillier, Ph.D.
Chief Operations Officer
Symbiotix Biotherapies, Moderna Therapeutics, Vertex Pharmaceuticals, Molecular Insight Pharmaceuticals, MIT
John M. Garvey, J.D., Ph.D.
Chief Legal Officer and General Counsel
DLA Piper LLP, K&L Gates LLP, Foley & Lardner LLP Parcell Laboratories Inc, Aesclepius Therapeutics
Head of Operations
Takeda, Boston Biochem, Millennium Pharmaceuticals, Johns Hopkins School of Public Health
Jacob Hesterman, Ph.D.
Chief Data Officer
Realm IDx, Invicro, Beth Israel Deaconess Medical Center, Bioscan, Inc
Stephen DiMagno, PhD
Head of Chemistry
UIC Pharmaceutical Sciences (Head), Ikaria (Co-founder), Osteoanalgesia, University of Nebraska, Ground Fluor Pharmaceuticals (Co-Founder), University of Pennsylvania, UC Berkeley